EZZ Life Science Holdings Stock

EZZ Life Science Holdings P/S 2024

EZZ Life Science Holdings P/S

0.65

Ticker

EZZ.AX

ISIN

AU0000130569

As of Sep 16, 2024, EZZ Life Science Holdings's P/S ratio stood at 0.65, a 1.56% change from the 0.64 P/S ratio recorded in the previous year.

The EZZ Life Science Holdings P/S history

EZZ Life Science Holdings Aktienanalyse

What does EZZ Life Science Holdings do?

EZZ Life Science Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding EZZ Life Science Holdings's P/S Ratio

EZZ Life Science Holdings's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing EZZ Life Science Holdings's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating EZZ Life Science Holdings's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in EZZ Life Science Holdings’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about EZZ Life Science Holdings stock

What is the price-to-earnings ratio of EZZ Life Science Holdings?

The price-earnings ratio of EZZ Life Science Holdings is currently 0.65.

How has the price-earnings ratio of EZZ Life Science Holdings changed compared to last year?

The price-to-earnings ratio of EZZ Life Science Holdings has increased by 1.56% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of EZZ Life Science Holdings high compared to other companies?

Yes, the price-to-earnings ratio of EZZ Life Science Holdings is high compared to other companies.

How does an increase in the price-earnings ratio of EZZ Life Science Holdings affect the company?

An increase in the price-earnings ratio of EZZ Life Science Holdings would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of EZZ Life Science Holdings affect the company?

A decrease in the price-earnings ratio of EZZ Life Science Holdings would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of EZZ Life Science Holdings?

Some factors that influence the price-earnings ratio of EZZ Life Science Holdings are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does EZZ Life Science Holdings pay?

Over the past 12 months, EZZ Life Science Holdings paid a dividend of 0.02 AUD . This corresponds to a dividend yield of about 0.69 %. For the coming 12 months, EZZ Life Science Holdings is expected to pay a dividend of 0.02 AUD.

What is the dividend yield of EZZ Life Science Holdings?

The current dividend yield of EZZ Life Science Holdings is 0.69 %.

When does EZZ Life Science Holdings pay dividends?

EZZ Life Science Holdings pays a quarterly dividend. This is distributed in the months of December, June, November, June.

How secure is the dividend of EZZ Life Science Holdings?

EZZ Life Science Holdings paid dividends every year for the past 7 years.

What is the dividend of EZZ Life Science Holdings?

For the upcoming 12 months, dividends amounting to 0.02 AUD are expected. This corresponds to a dividend yield of 0.76 %.

In which sector is EZZ Life Science Holdings located?

EZZ Life Science Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von EZZ Life Science Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of EZZ Life Science Holdings from 6/17/2024 amounting to 0.02 AUD, you needed to have the stock in your portfolio before the ex-date on 5/16/2024.

When did EZZ Life Science Holdings pay the last dividend?

The last dividend was paid out on 6/17/2024.

What was the dividend of EZZ Life Science Holdings in the year 2023?

In the year 2023, EZZ Life Science Holdings distributed 0.027 AUD as dividends.

In which currency does EZZ Life Science Holdings pay out the dividend?

The dividends of EZZ Life Science Holdings are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von EZZ Life Science Holdings

Our stock analysis for EZZ Life Science Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of EZZ Life Science Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.